Wuppertal, Germany

Ingo Kleiter

USPTO Granted Patents = 1 


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ingo Kleiter: Innovator in CNS Disease Treatments

Introduction

Ingo Kleiter, a prominent inventor based in Wuppertal, Germany, has made significant contributions to the field of medicine, particularly in addressing central nervous system (CNS) diseases. His research and inventions have the potential to improve the lives of those suffering from various neurological conditions.

Latest Patents

Ingo Kleiter holds one patent titled "SMAD7 inhibitors for the treatment of CNS diseases." This inventive work focuses on the use of specific inhibitors of Smad7 expression or function for preparing pharmaceutical compositions aimed at preventing, ameliorating, or treating diseases of the central nervous system. The patent also details methods for effectively preventing and treating such diseases, marking a notable advancement in therapeutic strategies for CNS disorders.

Career Highlights

Kleiter is associated with Giuliani International Limited, where he continues to explore innovative solutions within the medical field. His dedication and research efforts are evident in his patent work, showcasing his commitment to advancing healthcare.

Collaborations

In his professional journey, Ingo has worked alongside esteemed colleagues including Andreas Steinbrecher and Gerhard Giegerich. Their collaboration highlights the collective effort in groundbreaking research and the impact they strive to make in the healthcare sector.

Conclusion

Ingo Kleiter's innovations in the treatment of CNS diseases stand as a testament to his expertise and dedication. With his patented work paving the way for new therapeutic options, he continues to be a key player in the realm of medical inventions, contributing to the betterment of patient care and understanding of neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…